Home Stock UK’s CMA may accept Synopsys/Ansys deal remedies

UK’s CMA may accept Synopsys/Ansys deal remedies

by
0 comment

Investing.com — The UK’s Competition and Markets Authority (CMA) said it may accept the remedies offered by Synopsys (NASDAQ:SNPS) and Ansys (NASDAQ:ANSS). The agency now has until until March 5, 2025 to make an official decision. The undertakings, offered by both companies at the end of last year on December 31, include the divestment of certain product lines.

Specifically, Ansys has proposed to divest its product for power consumption analysis of digital chips. On the other hand, Synopsys has offered to divest its Optical Solutions Group. The CMA has stated that there are reasonable grounds to believe that these undertakings might be accepted.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You Might Also Like
  • STMicro cuts 2025-27 targets, shares down
  • The Santa Claus rally is real, BofA says
  • German retailers more pessimistic in holiday season, Ifo says
  • Nvidia added to upside 90-day catalyst watch at Citi

You may also like